| Pathogen/antimicrobial | No. (%) of pathogens | |
|---|---|---|
| Tested | Susceptible | |
| Staphylococcus aureus (n = 175) | ||
| Methicillin (cefazolin/cloxacillin/oxacillin) | 174 (99.4) | 133 (76.4) |
| Clindamycin | 134 (76.6) | 100 (74.6) |
| Erythromycin/azithromycin/clarithromycin | 126 (72.0) | 85 (67.5) |
| Fluoroquinolones | 94 (53.7) | 69 (73.4) |
| Penicillin | 112 (64.0) | 17 (15.2) |
| Trimethoprim-sulfamethoxazole | 159 (90.9) | 151 (95.0) |
| Doxycycline | 115 (65.7) | 108 (93.9) |
| Vancomycin | 115 (65.7) | 115 (100.0) |
| Coagulase-negative staphylococci (n = 117) | ||
| Methicillin (cefazolin/cloxacillin/oxacillin) | 85 (72.6) | 28 (32.9) |
| Clindamycin | 68 (58.1) | 29 (42.6) |
| Erythromycin/azithromycin/clarithromycin | 64 (54.7) | 24 (37.5) |
| Fluoroquinolones | 53 (45.3) | 15 (28.3) |
| Penicillin | 47 (40.2) | 2 (4.3) |
| Trimethoprim-sulfamethoxazole | 55 (47.0) | 30 (54.5) |
| Doxycycline | 48 (41.0) | 42 (87.5) |
| Vancomycin | 71 (60.7) | 71 (100.0) |
| Enterobacteriaceae (n = 432) | ||
| Amikacin | 186 (43.0) | 182 (97.8) |
| Amoxicillin-clavulanate | 183 (42.4) | 112 (61.2) |
| Ampicillin/amoxicillin | 399 (92.4) | 129 (32.3) |
| Carbapenems | 284 (65.7) | 280 (98.6) |
| Cefazolin | 360 (83.3) | 201 (55.8) |
| Ceftazidime | 257 (59.5) | 229 (89.1) |
| Ceftriaxone | 424 (98.1) | 356 (86.8)* |
| Fluoroquinolones | 413 (95.6) | 349 (84.5) |
| Gentamicin | 422 (97.7) | 398 (94.3) |
| Piperacillin-tazobactam | 428 (99.1) | 363 (91.0)† |
| Trimethoprim-sulfamethoxazole | 391 (90.5) | 327 (83.6) |
| Tobramycin | 352 (81.5) | 320 (90.9) |
| Non-Enterobacteriaceae‡ (n = 126) | ||
| Amikacin | 31 (24.6) | 30 (96.8) |
| (Primarily Pseudomonas aeruginosa, n = 71) | ||
| Carbapenems | 68 (54.0) | 55 (80.9) |
| Ceftazidime | 89 (70.6) | 79 (88.8) |
| Fluoroquinolones | 96 (76.2) | 81 (84.4) |
| Gentamicin | 82 (65.1) | 73 (89.0) |
| Piperacillin-tazobactam | 82 (65.1) | 70 (85.4) |
| Trimethoprim-sulfamethoxazole | 56 (44.4) | 28 (50.0) |
| Tobramycin | 71 (56.3) | 66 (93) |
| Streptococci (n = 213) | ||
| Ceftriaxone/cefotaxime | 116 (54.5) | 114 (98.3) |
| Clindamycin | 106 (49.8) | 93 (87.7) |
| Erythromycin/azithromycin/clarithromycin | 89 (41.8) | 65 (73.0) |
| Fluoroquinolones | 77 (36.2) | 77 (100) |
| Penicillin | 160 (75.1) | 149 (93.1) |
| Trimethoprim-sulfamethoxazole | 44 (20.6) | 36 (81.8) |
| Vancomycin | 109 (51.2) | 108 (99.1) |
| Enterococci (n = 156) | ||
| Ampicillin/amoxicillin | 153 (98.1) | 97 (63.4) |
| Vancomycin | 142 (91.0) | 119 (83.8) |
| Yeast (n = 94) | ||
| Fluconazole | 29 (30.8) | 27 (93.1) |
*Excludes 14 patients with missing susceptibility testing data from denominator.
†Excludes 29 patients with missing susceptibility testing data from denominator.
‡All non-Enterobacteriaceae in this grouping are gram-negative bacilli.